PD153035 hydrochloride

CAS No. 183322-45-4

PD153035 hydrochloride ( AG-1517 )

Catalog No. M12831 CAS No. 183322-45-4

PD153035 hydrochloride (ZM 252868; AG 1517) is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM; little effect against PGDFR, FGFR, CSF-1, InsR and Src.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 In Stock
10MG 56 In Stock
25MG 113 In Stock
50MG 221 In Stock
100MG 375 In Stock
500MG 853 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PD153035 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    PD153035 hydrochloride (ZM 252868; AG 1517) is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM; little effect against PGDFR, FGFR, CSF-1, InsR and Src.
  • Description
    PD153035 hydrochloride (ZM 252868; AG 1517) is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM; little effect against PGDFR, FGFR, CSF-1, InsR and Src.
  • Synonyms
    AG-1517
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR; EGFR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    183322-45-4
  • Formula Weight
    396.67
  • Molecular Formula
    C16H15BrClN3O2
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 0.5 mg/mL (1.26 mM)
  • SMILES
    COc(c1)c(OC)cc2c1ncnc2Nc3cc(Br)ccc3.Cl
  • Chemical Name
    N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fry DW, et al. Science. 1994, 265(5175), 1093-1095.
molnova catalog
related products
  • Tyrphostin B44, (+) ...

    Tyrphostin B44, (+) enantiomer is an inhibitor of epidermal growth factor receptor (EGFR) kinase with IC50 of 0.86 μM and has less active than the (-) enantiomer.

  • Genistein

    Genistein(NPI 031L), a phytoestrogen found in soy products, is a highly specific inhibitor of protein tyrosine kinase (PTK) which blocks the mitogenic effect mediated by EGF on NIH-3T3 cells with IC50 of 12μM or by insulin with IC50 of 19 μM.

  • CCF642

    CCF642 is a novel PDI-inhibiting compound with antimyeloma activity.